Login / Signup

Stroma biglycan expression can be a prognostic factor in prostate cancers.

Jun FurumidoNako MaishiAya Yanagawa-MatsudaHiroshi KikuchiRyuji MatsumotoTakahiro OsawaTakashige AbeYoshihiro MatsunoNobuo ShinoharaYasuhiro HidaKyoko Hida
Published in: International journal of urology : official journal of the Japanese Urological Association (2022)
This is the first study to show that stroma biglycan is a useful prognostic factor for prostate cancer.
Keyphrases
  • prognostic factors
  • prostate cancer
  • radical prostatectomy
  • poor prognosis
  • binding protein
  • young adults